Link: http://www.digiteklawsuit.org/

The manufacturers have recalled Digitek. Actavis Totowa (formerly Amide Pharmaceutical, Inc.), post findings that some of the tablets contained twice the approved level of the active ingredient used in the medicine immediately recalled its product from the shelves. The class I recall was initiated in April 2008 when the FDA started receiving reports of severe illnesses amongst patients who were administered a drub called Digitek. These tablets were a double-strength tablets that caused toxicity in the patients suffering from renal failure. These tablets caused a condition called Digitalis, which accumulated in the body instead of being passed out through urine. This dysfunction disrupts the proper functioning of the kidney and further aggravates the toxicity leading to problems, such as, nausea, vomiting, diarrhea, dizziness, low blood pressure, cardiac instability and bradycardia.

Digitek is another form of digitalis; it comes from a chemical derived from the ‘foxglove plant’. This has been used as a heart medicine since the 18th Century. The FDA (Food & Drug Administration) sited the recall as a Class I recall as the defective Digitek drug could cause potentially serious health problems or death. Few other symptoms of Digitalis toxicity include nausea, vomiting, diarrhea, dizziness, confusion, loss of appetite, low blood pressure, cardiac instability and irregular pulse, weakness, confusion, hallucinations, and heart palpitations. Some patients suffering from Digitalis or Digoxin toxicity may suffer from yellow vision in which objects and light appear yellow in color and blurred. Digoxin / Digitalis toxicity may also result in low heart rate called bradycardia and in increased or rapid heartbeat called tachycardia. Digitalis / Digoxin/ Digitoxin toxicity may cause severe weight loss due to the reduced appetite.

Despite reports of health issues in the consumers of Digitek, Actavis has did not take appropriate or necessary steps to provide the FDA with the information on how long and how many of these double-dosed pills have been in circulation. Many consumers have already filed lawsuit against Actavis for being negligent, irresponsible and for not warning the patients about the risks of consuming Digitek. It has also not been able to explain the reasons for such manufacturing faults. It is interesting to know that Actavis had received warnings from the FDA in 2006 and 2007 as well for violating the ‘Good Manufacturing Practices’ at their New Jersey plant. The letter sent by the FDA to Actavis categorically mentioned that it is difficult to ascertain whether the drugs are being manufactured using the right dosage.

The report further mentions that the out-of-specification (OSS) test results were not documented properly and the product was released based on retesting without providing any valid reasons for ignoring the initial OSS results.

Actavis responded to the FDA and promised to take the corrective action. While Actavis seemed sensitive towards the issue, the FDA felt that it should have done more by taking a quick action and bringing in an external agency to ensure that it is compliant with the good manufacturing practices.
As part of a Class I recall, all pharmacies are doing a double check on the list of their patients who have been prescribed this medicine and they are even calling up the patients informing them about the faulty medicines.

For more information about the Digitek Recall see Digitek Recall.

The manufacturers have recalled Digitek. Actavis Totowa (formerly Amide Pharmaceutical, Inc.), post findings that some of the tablets contained twice the approved level of the active ingredient used in the medicine immediately recalled its product from the shelves. The class I recall was initiated in April 2008 when the FDA started receiving reports of severe illnesses amongst patients who were administered a drub called Digitek. These tablets were a double-strength tablets that caused toxicity in the patients suffering from renal failure. These tablets caused a condition called Digitalis, which accumulated in the body instead of being passed out through urine. This dysfunction disrupts the proper functioning of the kidney and further aggravates the toxicity leading to problems, such as, nausea, vomiting, diarrhea, dizziness, low blood pressure, cardiac instability and bradycardia.
Digitek is another form of digitalis; it comes from a chemical derived from the ‘foxglove plant’. This has been used as a heart medicine since the 18th Century. The FDA (Food & Drug Administration) sited the recall as a Class I recall as the defective Digitek drug could cause potentially serious health problems or death. Few other symptoms of Digitalis toxicity include nausea, vomiting, diarrhea, dizziness, confusion, loss of appetite, low blood pressure, cardiac instability and irregular pulse, weakness, confusion, hallucinations, and heart palpitations. Some patients suffering from Digitalis or Digoxin toxicity may suffer from yellow vision in which objects and light appear yellow in color and blurred. Digoxin / Digitalis toxicity may also result in low heart rate called bradycardia and in increased or rapid heartbeat called tachycardia. Digitalis / Digoxin/ Digitoxin toxicity may cause severe weight loss due to the reduced appetite.
Despite reports of health issues in the consumers of Digitek, Actavis has did not take appropriate or necessary steps to provide the FDA with the information on how long and how many of these double-dosed pills have been in circulation. Many consumers have already filed lawsuit against Actavis for being negligent, irresponsible and for not warning the patients about the risks of consuming Digitek. It has also not been able to explain the reasons for such manufacturing faults. It is interesting to know that Actavis had received warnings from the FDA in 2006 and 2007 as well for violating the ‘Good Manufacturing Practices’ at their New Jersey plant. The letter sent by the FDA to Actavis categorically mentioned that it is difficult to ascertain whether the drugs are being manufactured using the right dosage.
The report further mentions that the out-of-specification (OSS) test results were not documented properly and the product was released based on retesting without providing any valid reasons for ignoring the initial OSS results.

Actavis responded to the FDA and promised to take the corrective action. While Actavis seemed sensitive towards the issue, the FDA felt that it should have done more by taking a quick action and bringing in an external agency to ensure that it is compliant with the good manufacturing practices.
As part of a Class I recall, all pharmacies are doing a double check on the list of their patients who have been prescribed this medicine and they are even calling up the patients informing them about the faulty medicines.

Link: http://www.digiteklawsuit.org/

Digitek has been voluntarily recalled by its manufacturer, Actavis Totowa (formerly Amide Pharmaceutical, Inc.), after it was suspected that some of the tablets may contain twice the approved level of the active ingredient used in the medicine. The class I recall happened in April 2008 when the FDA had received the reports of severe illnesses amongst patients using Digitek. These double-strength tablets may cause toxicity in the patients suffering from renal failure, which causes digitalis to accumulate in the body instead of being passed out through urine. This disrupts the proper functioning of the kidney and further aggravates the toxicity leading to problems, such as, nausea, vomiting, diarrhoea, dizziness, low blood pressure, cardiac instability and bradycardia.

What is Digitek?
Digitek tablets are prescribed to those patients who suffer serious heart problems, such as, irregular heartbeat, arterial fibrillation, and congestive heart failure. It is available in tablet, capsule, liquid, and injectable forms, however the Digitek recall relates only to the tablets.

How did it happen?
Despite reports of health issues in the consumers of Digitek, Actavis has failed to provide them the information on how long and how many of these double-dosed pills have been in circulation. Many consumers have already filed lawsuit against Actavis for not warning the patients about the risks of consuming Digitek. It has also not been able to explain the reasons for such manufacturing faults. It is interesting to know that Actavis had received warnings from the FDA in 2006 and 2007 as well for violating the ‘Good Manufacturing Practices’ at their New Jersey plant. The letter sent by the FDA to Actavis categorically mentioned that it is difficult to ascertain whether the drugs are being manufactured using the right dosage.
It further mentions that the out-of-specification (OSS) test results were not documented properly and the product was released on the basis of retesting without providing any valid reasons for ignoring the initial OSS results.

In response to the FDA’s warning letter, Actavis responded by promising to take the corrective action. While Actavis seemed sensitive towards the issue, the FDA felt that it should have done more by taking a quick action and bringing in an external agency to ensure that it’s compliant with the good manufacturing practices.

Corrective measures
Pharmacies have been asked to check the list of their patients who have purchased Digitek and to personally inform them about the faulty medicine. The patients, who have consumed the medicine between March 2006 and April 2008, have been asked to consult their physicians and return the medicine to their suppliers.

For more information about the Digitek recall see Digitek Recall.

Link: http://www.digiteklawsuit.org/

A Digitek Recall Lawsuit has stemmed from a FDA class I recall of the drug Digitek. The Digitek Recall Lawsuit states that Actavis Totowa who manufactures Digitek did not comply with certain Federal Regulations and due to manufacturing errors, certain lots of the Digitek Recall Lawsuit tablets were produced containing twice the active ingredient Digoxin which can lead to severe medical complications such as seizures, cardiac instability, and even death. The Digitek Recall Lawsuit alleges that this Digitek manufacturing error would not have occurred if Actavis Totowa had reacted adequately to previous FDA warnings about meeting certain manufacturing safety standards where the Digitek Recall Lawsuit tablets were being produced.

Due to the serious medical conditions that could arise from Digitek toxcicity, the Digitek Recall Lawsuit plaintiffs are looking for compensation for their injuries as well as future health problems associated with taking the Digitek Recall Lawsuit tablets that were double dosed. If you are one of the many people who have taken Digitek and experienced certain adverse reactions, you may want to be part of the Digitek Recall Lawsuit. If you are looking for a Digitek Lawsuit lawyer, make sure your attorney has experience in working with medical malpractice cases. These types of cases go on for months on end, sometimes years before reaching any type of settlement. Make sure your lawyer involved in the Digitek lawsuit will fight for you. You want to have an open line of communication with your Digitek lawyer and know that they will communicate with you as the case progresses. Make sure you are comfortable in talking with your Digitek lawyer and that they have the legal expertise to guide you through the Digitek Recall Lawsuit.

Digitek is prescribed for people who have cardiac problems such as irregular heartbeat, artrial fibrillation, and congestive heart failure. The Digitek Recall Lawsuit was started because some of the Digitek tablets contained twice the regular dose due to a manufacturing error. Involved in the Digitek Recall Lawsuit are those that were prescribed these tablets and experienced certain severe medical complications from taking the Digitek Lawsuit double dosed tablets. There are many families who are taking part in the Digitek Recall Lawsuit because of the medical problems they now have associated with the recalled Digitek tablets. If you are one of these people who were prescribed Digitek, you may want to contact a Digitek Lawyer who is familiar with the Digitek Recall Lawsuit.

Our lawyers are here to help answer your questions about the Digitek Recall Lawsuit. If you are seeking answers or want more information about the Digitek class action lawsuit, fill out the provided webpage form and a Digitek Lawyer will contact you.

Link: http://www.digiteklawsuit.org/

In April of 2008 a letter was issued by Actavis Totowa issuing a voluntary recall of their drug Digitek. At the time of the Digitek recall, the FDA had already received several reports of illnesses and medical events related to Digitek treatment.
The Food & Drug Administration (FDA) deemed the Digitek recall a Class I recall, meaning that the defective Digitek tablets could cause serious health problems or death.

Digitek (Digoxin) is a drug is used to treat artrial fibrillation and heart rhythm disorders by helping the heart beat stronger and with a more regular rhythm. Digitek is available in tablet, capsule, liquid, and injectable forms, however the recall pertains only to the tablets. The reason for the Digitek recall was due to the possibility that some of the tablets contained twice the approved dosage. Medical providers have found that tablets subject to the Digitek recall, if ingested, can result in severe medical complications, generally caused by digitalis toxicity, which is a medical condition that can lead to very serious side effects, sometimes including death

A Digitek class action lawsuit was filed in US District Court in New Jersey after April's Digitek recall brought to light significant questions about how the defective pills were manufactured.How does this happen one might ask themselves and how can we foresee a “Digitek recall”. Would having a crystal ball help? Maybe, but in this case reading the warning letter Actavis Totowa received back in 2006 for failing to provide periodic safety reports at its facility where Digitek was manufactured would certainly give us some insight.

Because of the severe risk of Digitek toxicity associated with this manufacturing error, individuals who currently take or have taken the drug should consider developing a Digitek lawsuit. Some of these lawsuits allege that the Digitek recall would not have been necessary if Actavis Totowa had adequately responded to earlier warnings from the FDA about the quality of the Digitek being produced. Additional information about the recall can also be found at Digitek Recallwebsite.

The plaintiffs in the Digitek lawsuit are seeking compensation for their injuries as well as medical monitoring in case they experience future health problems. With a Digitek lawsuit, our lawyers may help you get reimbursed for expenses such as medical bills, loss of income, and pain and suffering.

We are pursuing individual litigation nationwide and currently accepting new Digitek recall and Digitalis toxicity cases in all 50 states.If you would like to discuss your legal rights or want more information on the Digitek recall lawsuit, our experienced lawyers would be happy to answer your questions. Click Digitek Attorney for a Digitek recall attorney consultation.